Mark Novell - 11 Apr 2023 Form 4 Insider Report for Cano Health, Inc.

Role: Chief Accounting Officer
Signature: /s/ David J. Armstrong, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 11 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 13 Apr 2023, 21:15:55 UTC
Previous filing: 09 Jan 2023
Next filing: 02 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CANO	Class A Common Stock	Award		+51,684	+43%		171,565	11 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CANO	Stock Option (Right to Buy)	Award	$0	+32,131		$0.000000	32,131	11 Apr 2023	Class A Common Stock	32,131	$1.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31, 2023 and the remaining 50% of the RSUs vest on December 31, 2024. The RSUs were granted on April 11, 2023.
F2	The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on April 11, 2024, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on April 11, 2023.